Education
About Us
Working with TipRanks
Follow Us
Arch Biopartners (TSE:ARCH)
:ARCH
Lsalt Peptide
Acute Kidney Injury, Cardiac Surgery
Phase II
Recruiting
LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery
May 18, 2023
―
Lsalt Peptide
Covid, Acute Kidney Injury, Acute Respiratory Distress Syndrome, Sars-Cov2, Severe Acute Respiratory Syndrome
Phase II
Completed
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
May 12, 2020
―
0.9% Saline, Lsalt Peptide
None - Study Is To Determine Safety In Healthy Participants
Early Phase I
Completed
A Phase I Study to Evaluate LSALT Peptide
Dec 09, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arch Biopartners (ARCH) have in its pipeline
ARCH is currently developing the following drugs: Lsalt Peptide, Lsalt Peptide, 0.9% Saline, Lsalt Peptide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.